Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	2,373,409
Curr. Assets	:	2,639,884
Fixed Assets	:	1,176,172
Total Assets	:	3,816,056
Curr. Liabilities	:	183,643
Long Term Debt	:	340,252
Minority Interest	:	0
Total Liabilities	:	523,895
Paid-Up Capital	:	1,750
Total Equity	:	3,292,161
Income Statement
Total Sales	:	174,795
Gross Profit	:	40,130
Operating Profit	:	42,240
Net Income	:	42,240
Cash Flow Statement
Cash From Operating Act	:	65,587
Cash From Investing Act	:	58,071
Cash From Financing Act	:	-36,673
Per Share Data (in IDR)
EPS	:	24.14
Book Value	:	1,881.21
Financial Ratios
Der	:	0.16
Roa	:	0.97
Roe	:	0.05
Npm	:	0.24
Opm	:	0.24
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion

2	Illumina and PREMIA partner to expand clinical access to CGP in Asia

3	Rokid and Ant International Announce Integration of Smart Glasses Payment Capability

4	Salcomp's Debut on CES 2026

5	Call for Application for 2026 Tsinghua Amgen Scholars Program

RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion